Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa

The Lancet HIV · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles